Brightlands Venture Partners

Grassa BV specializes in the valorization of plant-based streams through bioraffinage. Based in the Netherlands, Grassa converts grass and vegetable waste into high-quality, protein-rich animal feed and other valuable products using its mobile bio-refinery technology. This process generates four main outputs: fibers, protein, phosphate, and 'wei' (sap). By transforming locally available green residual flows such as grass from meadows, agricultural waste, water plants, or nature grass, Grassa supports sustainable agriculture and helps farmers enhance their income while addressing food scarcity.

PL BioScience GmbH is a biotechnology company based in Aachen, Germany, specializing in the development and manufacture of cell culture products derived from human platelet lysate. Founded in 2015, the company provides a range of products tailored for stem cell research, including research grade, GMP grade, and customized formulations, as well as fibrinogen-depleted and gamma-irradiated products. PL BioScience also offers advanced 2D and 3D cell culture solutions, cell culture medium kits, primary cells, and related support services. Its offerings are designed to facilitate safe and reproducible cellular growth for basic research, cellular therapeutics, and clinical applications. Through its online platform, PL BioScience meets the increasing demand for high-quality cell culture media essential for various stages of research and development within the biotech and life sciences sectors.

Vivalyx is a healthcare company focused on improving organ transplantation outcomes. It specializes in developing a cost-effective solution for preserving organs, aiming to enhance their vitality and increase the available number for transplantation. The company's technology eliminates the need for donor blood or human products, making it a versatile option for various preservation applications. By doing so, Vivalyx supports doctors in extending organ viability, ultimately benefiting patients suffering from organ failure worldwide.

Qorium is a biotechnology company that specializes in the production of cell-cultured collagen-based leather. By utilizing advanced cell culturing and tissue engineering technologies, Qorium aims to create premium, sustainable leather alternatives that significantly reduce the environmental impact associated with traditional leather manufacturing. Its innovative approach ensures that the materials are independent of the meat industry and do not contribute to deforestation for livestock, offering consumers a high-quality, animal-free leather option.

Matisse Pharmaceuticals B.V. is a biotechnology company based in Geleen, the Netherlands, specializing in the development of pharmaceutical therapies aimed at treating sepsis and related disorders associated with fulminant inflammation. Founded in 2014, the company is focused on creating innovative treatments to neutralize cytotoxic components of the inflammatory system. Its lead product, M6229, is currently in the pre-clinical phase and targets severe sepsis and septic shock, aiming to provide healthcare professionals with advanced therapeutic options to improve patient outcomes in critical conditions.

Corporis Medical is an emerging medical device company dedicated to the development and commercialization of innovative surgical tools. The company specializes in creating diagnostic instruments for minimally invasive procedures, particularly in laparoscopic and bowel surgery. Their products are designed to prevent anastomotic leakages, enabling surgeons to assess the quality of anastomoses in real-time during operations. By improving surgical access and closure, as well as diagnostic measurements, Corporis Medical aims to enhance patient outcomes and reduce postoperative complications, ultimately lowering healthcare costs associated with surgical procedures.

ReSolved Technologies specializes in recycling engineering plastics and polyvinyl chloride from complex waste streams. Utilizing a unique solvent-based technology, the company extracts and converts these plastics into high-purity recycled material, equivalent to virgin quality. This recycled product is suitable for use in high-end markets, facilitating closed-loop recycling and enabling businesses to enhance their sustainability performance by reducing their carbon footprint and increasing product circularity.

Circularise is a provider of digital product passports and mass balance bookkeeping software, focusing on sustainability and supply chain transparency. The company’s software aids suppliers, manufacturers, recyclers, and brands across various industries, including chemicals, plastics, and metals, in tracing materials and sharing their environmental footprint securely. Its primary offering, the digital product passport, compiles detailed records of a product's origin, material composition, and environmental data, supported by a blockchain-powered chain of custody for data security. Circularise's platform enables companies to assess their Scope 3 emissions and comply with regulatory requirements related to sustainability. Furthermore, it offers tools for conducting Life Cycle Assessments and calculating Product Carbon Footprints, ensuring a reliable record of environmental impact. The MassBalancer solution helps manage materials while adhering to defined processes, enabling efficient generation of sustainability declarations. Central to Circularise’s approach is the patented Smart Questioning feature, which empowers clients to control their data sharing, thereby enhancing privacy and minimizing manual errors in reporting sourcing, carbon footprint, and human rights issues.

Greencovery specializes in food upcycling technology that allows food companies to produce sustainable ingredients from side-stream production. The company's proprietary platform accelerates the time-to-market for new ingredients, focusing on savory flavors, supplements such as amino acids, proteins, fruity flavors, and fibers. By enabling the recovery of valuable ingredients that would otherwise be discarded, Greencovery helps its customers enhance the feasibility and sustainability of their businesses. The ingredients produced have a low carbon footprint, are sourced close to market, and offer high functionality, making them suitable for various applications in the growing sports nutrition, beverages, and protein alternatives sectors.

S+dB B.V. specializes in enhancing plant seed technology, focusing on improving seed germination, seedling establishment, and seed handling. Established in 2014 and located in Weert, the Netherlands, the company develops innovative seed-embedding technology that supports optimal growth conditions during critical phases of seed development. Their SET platform technology not only enhances seed vigor and guarantees uniform crop growth with a robust root foundation, but it also offers weed control and protection against environmental stresses. S+dB provides a range of grass seed products suitable for both domestic gardening and professional markets, ensuring that their solutions are scalable and adaptable for various applications.

Niostem is a venture-funded startup focused on addressing hair loss through innovative wearable regenerative technologies. The company is dedicated to harnessing the body's natural healing abilities, particularly the function of adult stem cells, to promote hair regrowth. Niostem is in the process of developing a smart, wearable device that aims to reactivate physiological hair growth and halt hair loss, specifically targeting individuals experiencing male pattern baldness. By restoring the body's capacity for regeneration, Niostem seeks to provide an effective solution for preventing hair loss without resorting to drugs or invasive procedures.

Verdify is a foodtech company that specializes in developing software for personalized online meal inspiration. Its platform allows users to create a fully customized experience by tailoring recipe content to match individual nutrition profiles, dietary preferences, and lifestyle choices. The application enables users to convert traditional recipes into alternative versions, such as plant-based or gluten-free, ensuring that diverse dietary needs are met. Additionally, Verdify's technology integrates recipe advertising, promoting future-focused food brands within the online recipe context. Through its innovative approach, Verdify empowers individuals to make healthier food choices that align with both personal health goals and sustainability considerations.

Neuroplast is a biotechnology company that specializes in neuro-regenerative personalized medicine, focusing on the development of autologous stem cell products. The company aims to address critical medical conditions such as spinal cord injuries, amyotrophic lateral sclerosis, and traumatic brain injuries. By isolating, manufacturing, and reinserting patients' own cells, Neuroplast’s platform enhances the potential for successful treatment and aims to improve the quality of life for patients. The company is committed to establishing dedicated standards and regulations within the rapidly evolving field of regenerative medicine to ensure the efficacy and safety of its therapies.

Vertoro is a company that specializes in converting woody and agricultural residues into bio-based chemicals, materials, and fuels. It produces crude lignin oil and crude sugar oil from these residues, providing a sustainable alternative to fossil resources. The oils generated by Vertoro serve as liquid raw materials for the petrochemical industry and can effectively replace fossil crude oil in the production of various materials, chemicals, and fuels. By focusing on transforming waste into valuable resources, Vertoro aims to contribute to a more sustainable and circular economy.

Qorium is a biotechnology company that specializes in the production of cell-cultured collagen-based leather. By utilizing advanced cell culturing and tissue engineering technologies, Qorium aims to create premium, sustainable leather alternatives that significantly reduce the environmental impact associated with traditional leather manufacturing. Its innovative approach ensures that the materials are independent of the meat industry and do not contribute to deforestation for livestock, offering consumers a high-quality, animal-free leather option.

Black Bear Carbon BV specializes in the conversion of waste tires into carbon black and green energy, operating from its base in Nederweert, the Netherlands, since its founding in 2010. The company utilizes a circular economy model, transforming end-of-life tires into sustainable products that serve various industries. Its carbon black, derived from controlled pyrolysis and partial combustion of hydrocarbons, is utilized in applications such as tires, technical rubber products, plastics, paints, and inks. In addition to producing carbon black, Black Bear Carbon generates electricity from its operations, which powers its tire shredding processes and supplies energy to local industries and grids. Through these efforts, the company provides businesses with recyclable carbon compounds, contributing to reduced reliance on oil and lower carbon dioxide emissions.

Neuroplast is a biotechnology company that specializes in neuro-regenerative personalized medicine, focusing on the development of autologous stem cell products. The company aims to address critical medical conditions such as spinal cord injuries, amyotrophic lateral sclerosis, and traumatic brain injuries. By isolating, manufacturing, and reinserting patients' own cells, Neuroplast’s platform enhances the potential for successful treatment and aims to improve the quality of life for patients. The company is committed to establishing dedicated standards and regulations within the rapidly evolving field of regenerative medicine to ensure the efficacy and safety of its therapies.

AVL Motion BV is a Netherlands-based company that specializes in the development of autonomous harvesting robots, particularly designed for selective crops such as white asparagus, green asparagus, and zucchini. By focusing on automating labor-intensive harvesting processes, AVL Motion aims to enhance efficiency in the agricultural sector, particularly for small and medium-sized enterprises. Their innovative technology allows for the precise movement and harvesting of crops, thereby facilitating labor reduction and process optimization. The company is committed to advancing industrial automation within horticulture, creating tailored solutions that meet the specific needs of the food industry.

VACIS is a pioneering company in the field of tissue engineering, specializing in the development of in situ tissue engineered blood vessels. The company addresses a significant issue in vascular surgery: the frequent failure of prosthetic vascular grafts, which leads to substantial morbidity and healthcare costs. VACIS' innovative approach involves using a synthetic rod with a specialized surface that is inserted under the skin. This induces the body to form a tissue capsule, which matures into a functional blood vessel. These autologous graft vessels offer sustained patency and fewer complications, reducing the need for corrective interventions. The technology is particularly beneficial for creating vascular access sites for hemodialysis, providing physicians with a reliable method to create blood vessels that are protected from foreign materials.

Grassa BV specializes in the valorization of plant-based streams through bioraffinage. Based in the Netherlands, Grassa converts grass and vegetable waste into high-quality, protein-rich animal feed and other valuable products using its mobile bio-refinery technology. This process generates four main outputs: fibers, protein, phosphate, and 'wei' (sap). By transforming locally available green residual flows such as grass from meadows, agricultural waste, water plants, or nature grass, Grassa supports sustainable agriculture and helps farmers enhance their income while addressing food scarcity.

Hy2Care BV is a start-up emerging from the University of Twente in the Netherlands, focused on developing innovative treatments for osteoarthritis, a condition that affects over 100 million individuals in the Western world. The company's primary product is an injectable hydrogel designed to repair cartilage defects, specifically in the knee. This bioresorbable hydrogel consists of a two-component system made from a mixture of natural polymer conjugates that undergo a mild enzymatic reaction to form a cross-linked structure. Hy2Care aims to provide an effective treatment option for osteoarthritis, addressing a significant unmet medical need and enhancing the quality of life for patients suffering from this debilitating condition.

Hy2Care BV is a start-up emerging from the University of Twente in the Netherlands, focused on developing innovative treatments for osteoarthritis, a condition that affects over 100 million individuals in the Western world. The company's primary product is an injectable hydrogel designed to repair cartilage defects, specifically in the knee. This bioresorbable hydrogel consists of a two-component system made from a mixture of natural polymer conjugates that undergo a mild enzymatic reaction to form a cross-linked structure. Hy2Care aims to provide an effective treatment option for osteoarthritis, addressing a significant unmet medical need and enhancing the quality of life for patients suffering from this debilitating condition.